Beijing Bayi Space LCD Technology Co., Ltd. is a China-based enterprise primarily engaged in the research, development, manufacture, and distribution of advanced electronic display materials, semiconductor electronic chemicals, and specialty pharmaceutical intermediates. Founded in July 2004 and headquartered in Beijing, China, the company operates across display materials, semiconductor materials, and fine chemical industry segments. The company's core product portfolio comprises high-performance thin-film transistor liquid crystal display (TFT-LCD) materials, including twisted nematic (TN), super-twisted nematic (STN), in-plane switching (IPS), and vertical alignment (VA) mixed liquid crystal formulations; organic light-emitting diode (OLED) materials, including OLED functional intermediates and sublimation precursor compounds; polymer-dispersed liquid crystal (PDLC) smart dimming films and switchable film materials; photosensitive polyimide (PSPI) materials utilized in flexible display alignment and advanced semiconductor packaging; electronic-grade photoresist materials, including semiconductor KrF (248nm) lithography photoresist resins and core polymer monomers; and specialty pharmaceutical chemical materials, including advanced active pharmaceutical ingredients (APIs) and customized chemical intermediates. The company distributes its products across mainland China and international markets, primarily supplying leading flat-panel display manufacturers, including BOE Technology Group, HKC Corporation, TCL China Star Optoelectronics Technology (CSOT), and Tianma Microelectronics, alongside semiconductor fabrication suppliers and pharmaceutical manufacturers. In recent strategic developments, the company has actively expanded beyond display liquid crystals to build a comprehensive electronic materials platform. Through its wholly owned subsidiary Zhejiang Bayi Space Advanced Materials Co., Ltd., the company completed and commissioned a hundred-ton-scale automated KrF photoresist resin production facility in Shangyu, Zhejiang Province. Additionally, the company formed a strategic partnership and introduced Xiamen Hengkun New Material Technology Co., Ltd. as a strategic equity investor in Shanghai Bayi Space Advanced Materials Co., Ltd. to accelerate development and downstream verification of advanced lithography photoresist products. In its specialty chemicals division, the company commenced trial production at its Cangzhou manufacturing base in Hebei Province, completing customer qualification and transitioning advanced psychiatric pharmaceutical intermediates into commercial production.